Truveris
PrivateLast Round
Series E
May 14, 2024
Total Funding Raised
$66.55M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Truveris operates in Healthcare & Life Sciences and is based in Wilmington, Delaware. Its latest recorded funding round was a Series E round in May 2024.
Truveris is a healthcare technology company that provides a pharmacy benefits procurement and insights platform to reduce prescription drug costs.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Pharma Supply Chain, Compliance & Risk
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Marketplace Commission, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Truveris Comparables
Compare Truveris with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rivera | 83% | |
| EVERSANA | 81% | |
| RxBenefits | 79% |
For institutional investors. Book with your work email.
Truveris Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | May 14, 2024 | ||||
| Series D | Sep 6, 2017 | ||||
| Series C | Jun 27, 2014 | ||||
| Series B | Feb 23, 2012 | ||||
| Series A | Feb 1, 2011 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Truveris Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GSA Venture Partners | Series A |
| New Leaf Venture Partners | Series C, Series D, Series E, Series B |
| McKesson Ventures | Series D |
| Canaan Partners | Series D, Series E, Series C |
| First Round Capital | Series C, Series B, Series A |
| NAV.VC | Series C, Series B, Series D, Series A |
| Tribeca Venture Partners | Series C, Series B, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 185, 3.4x the trailing average.
- Jun 17, 2026
Monthly visitors increased 80% MoM.
For institutional investors. Book with your work email.
Truveris Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Truveris's valuation, stock price, and market status.
Is Truveris a public or private company?
Truveris is a private company.
What is the current stock price of Truveris?
Truveris is a private company, so its shares have no public market price. Caplight tracks Truveris's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Truveris worth (valuation)?
Valuation information for Truveris is not publicly available.
Can I buy Truveris stock?
Truveris shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Truveris's last funding round?
Truveris's most recent funding round was Series E on May 14, 2024.
Who are the main investors in Truveris?
Key investors in Truveris include GSA Venture Partners, New Leaf Venture Partners, McKesson Ventures, Canaan Partners.
Will Truveris IPO soon?
No public IPO plans have been announced for Truveris.
How can I track Truveris secondary market activity?
Caplight tracks bids, offers, and trades in Truveris's shares on secondary markets.